Literature DB >> 23525871

Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents.

Nalini N E Radhakishun1, Mariska van Vliet, Ines A von Rosenstiel, Olivier Weijer, Jos H Beijnen, Dees P M Brandjes, Michaela Diamant.   

Abstract

BACKGROUND: Contrasting data exist regarding the relationship between thyroid-stimulating hormone (TSH) and obesity-related risk factors in children. In the present study, we investigated the association between TSH, free T4 (fT4) and cardiometabolic risk factors in euthyroid obese children and adolescents.
METHODS: A retrospective analysis of patient records was performed on data from 703 multi-ethnic obese children and adolescents who visited an obesity-outpatient clinic. We performed anthropometric measurements, an oral glucose tolerance test, and measured serum TSH, fT4 and lipid levels.
RESULTS: A positive association between TSH and the standard deviation score of the body mass index (BMI-Z) was found. After adjustment for ethnicity, sex, pubertal stage and BMI-Z, logistic regression analysis showed significant associations between TSH levels and impaired fasting glucose, impaired glucose tolerance, high total cholesterol, high low-density lipoprotein cholesterol and high triglycerides. No significant associations between fT4 levels and cardiometabolic risk factors were found in linear/logistic regression analysis.
CONCLUSION: In our multi-ethnic cohort of euthyroid obese children and adolescents increasing TSH was associated with impaired glucose metabolism and dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23525871     DOI: 10.1515/jpem-2012-0302

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  The effect of obesity-related allostatic changes on cardio-metabolic risk in euthyroid children.

Authors:  A Tropeano; D Corica; S Curatola; A Li Pomi; C Casto; A Alibrandi; G Pepe; T Aversa; M Wasniewska
Journal:  J Endocrinol Invest       Date:  2022-08-20       Impact factor: 5.467

2.  Pituitary response to thyrotropin releasing hormone in children with overweight and obesity.

Authors:  Jesse Rijks; Bas Penders; Elke Dorenbos; Saartje Straetemans; Willem-Jan Gerver; Anita Vreugdenhil
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

3.  The Adverse Effects of Thyrotropin Absence on Pancreatic β Cell Function in Mice.

Authors:  Yu Yang; Yu Chen; Jie Chen; Danyu Zhang; Jianhua Wang; Xiaodong Mao; Xiao Wei; Xingjia Li; Xianghua Ma; Chao Liu; Kun Wang
Journal:  J Diabetes Res       Date:  2019-04-15       Impact factor: 4.011

4.  Retrospective cohort analysis comparing changes in blood glucose level and body composition according to changes in thyroid-stimulating hormone level.

Authors:  Hyunah Kim; Da Young Jung; Seung-Hwan Lee; Jae-Hyoung Cho; Hyeon Woo Yim; Hun-Sung Kim
Journal:  J Diabetes       Date:  2022-09-16       Impact factor: 4.530

5.  Thyroid Function and Thyroid Autoimmunity in Relation to Weight Status and Cardiovascular Risk Factors in Children and Adolescents: A Population-Based Study.

Authors:  Emilio García-García; María A Vázquez-López; Eduardo García-Fuentes; Rafael Galera-Martínez; Carolina Gutiérrez-Repiso; Icíar García-Escobar; Antonio Bonillo-Perales
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-01-18

6.  Subclinical Hypothyroidism in Danish Lean and Obese Children and Adolescents.

Authors:  Maria Dahl; Johanne Dam Ohrt; Cilius Esmann Fonvig; Julie Tonsgaard Kloppenborg; Oluf Pedersen; Torben Hansen; Jens Christian Holm
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-09-09

7.  Thyroid Stimulating Hormone (TSH) Is Associated With General and Abdominal Obesity: A Cohort Study in School-Aged Girls During Puberty in East China.

Authors:  Yingying Wang; Xiaolian Dong; Chaowei Fu; Meifang Su; Feng Jiang; Dongli Xu; Rui Li; Junhua Qian; Na Wang; Yue Chen; Qingwu Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-30       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.